241
Views
42
CrossRef citations to date
0
Altmetric
Original Articles

Expression Level of ABCG2 in the Placenta Decreases from the Mid Stage to the End of Gestation

, , &
Pages 1871-1876 | Received 19 Apr 2005, Accepted 13 Jul 2005, Published online: 22 May 2014

  • 1) Allikmets, R., Schriml, L. M., Hutchinson, A., Romano-Spica, V., and Dean, M., A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res., 58, 5337–5339 (1998).
  • 2) Allen, J. D., Brinkhuis, R. F., Wijnholds, J., and Schinkel, A. H., The mouse Bcrp1/Mxr/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin. Cancer Res., 59, 4237–4241 (1999).
  • 3) Volk, E. L., and Schneider, E., Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter. Cancer Res., 63, 5538–5543 (2003).
  • 4) Imai, Y., Asada, S., Tsukahara, S., Ishikawa, E., Tsuruo, T., and Sugimoto, Y., Breast cancer resistance protein exports sulfated estrogens but not free estrogens. Mol. Pharmacol., 64, 610–618 (2003).
  • 5) Ifergan, I., Jansen, G., and Assaraf, Y. G., Cytoplasmic confinement of breast cancer resistance protein (BCRP/ABCG2) as a novel mechanism of adaptation to short-term folate deprivation. Mol. Pharmacol., 67, 1349–1359 (2005).
  • 6) Novotna, M., Libra, A., Kopecky, M., Pavek, P., Fendrich, Z., Semecky, V., and Staud, F., P-glycoprotein expression and distribution in the rat placenta during pregnancy. Reprod. Toxicol., 18, 785–792 (2004).
  • 7) Mizuarai, S., Aozasa, N., and Kotani, H., Single nucleotide polymorphisms result in impaired membrane localization and reduced ATPase activity in multidrug transporter ABCG2. Int. J. Cancer, 109, 238–246 (2004).
  • 8) Honjo, Y., Morisaki, K., Huff, L. M., Robey, R. W., Hung, J., Dean, M., and Bates, S. E., Single-nucleotide polymorphism (SNP) analysis in the ABC half-transporter ABCG2 (MXR/BCRP/ABCP1). Cancer Biol. Ther., 1, 696–702 (2002).
  • 9) Ifergan, I., Shafran, A., Jansen, G., Hooijberg, J. H., Scheffer, G. L., and Assaraf, Y. G., Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression: a role for BCRP in cellular folate homeostasis. J. Biol. Chem., 279, 25527–25534 (2004).
  • 10) Casey, M. L., and MacDonald, P. C., Endocrine changes of pregnancy. In “Williams Textbook of Endocrinology” 9th ed., eds. Wilson, J. D., Foster, D. W., and Kronenberg, H. M., Saunders, Philadelphia, pp. 1259–1271 (1998).
  • 11) Orlowski, S., Mir, L. M., Belehradek, J., Jr., and Garrigos, M., Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators. Biochem. J., 317, 515–522 (1996).
  • 12) Ee, P. L., Kamalakaran, S., Tonetti, D., He, X., Ross, D. D., and Beck, W. T., Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene. Cancer Res., 64, 1247–1251 (2004).
  • 13) Hori, S., Ohtsuki, S., Tachikawa, M., Kimura, N., Kondo, T., Watanabe, M., Nakashima, E., and Terasaki, T., Functional expression of rat ABCG2 on the luminal side of brain capillaries and its enhancement by astrocyte-derived soluble factor(s). J. Neurochem., 90, 526–536 (2004).
  • 14) Tanaka, Y., Slitt, A. L., Leazer, T. M., Maher, J. M., and Klaassen, C. D., Tissue distribution and hormonal regulation of the breast cancer resistance protein (Bcrp/Abcg2) in rats and mice. Biochem. Biophys. Res. Commun., 326, 181–187 (2005).
  • 15) Imai, Y., Ishikawa, E., Asada, S., and Sugimoto, Y., Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2. Cancer Res., 65, 596–604 (2005).
  • 16) Conneely, O. M., and Lydon, J. P., Progesterone receptors in reproduction: functional impact of the A and B isoforms. Steroids, 65, 571–577 (2000).
  • 17) Wen, D. X., Xu, Y. F., Mais, D. E., Goldman, M. E., and McDonnell, D. P., The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Mol. Cell. Biol., 14, 8356–8364 (1994).
  • 18) Tung, L., Mohamed, M. K., Hoeffler, J. P., Takimoto, G. S., and Horwitz, K. B., Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. Mol. Endocrinol., 7, 1256–1265 (1993).
  • 19) Spencer, F., Chi, L., and Zhu, M., Temporal relationships among uterine pituitary adenylate cyclase-activating polypeptide, decidual prolactin-related protein and progesterone receptor mRNAs expressions during decidualization and gestation in rats. Comp. Biochem. Physiol. C. Toxicol. Pharmacol., 129, 25–34 (2001).
  • 20) Cheng, K. W., Cheng, C. K., and Leung, P. C., Differential role of PR-A and -B isoforms in transcription regulation of human GnRH receptor gene. Mol. Endocrinol., 15, 2078–2092 (2001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.